Leidos Partnership Deploys MHS GENESIS Overseas in First of Two Planned OCONUS Waves
RESTON, Va., Oct. 17, 2023 /PRNewswire/ -- The Leidos Partnership for Defense Health (LPDH) today announced it successfully delivered the MHS GENESIS electronic health record to an additional 9,000 Department of Defense (DOD) clinicians and providers as part of its first Outside of the Contiguous United States (OCONUS) deployment (Waves LANDSTUHL/LAKENHEATH). The current system deployment spans 10 Military Treatment Facilities (MTFs) across Europe and the United Kingdom. Additionally, LPDH deployed MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba.
- Additionally, LPDH deployed MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba.
- With this latest overseas DOD wave deployment, the MHS GENESIS system is now operational at over 3,500 locations and now reaches over seven million DOD beneficiaries.
- MHS GENESIS is 91% deployed to DOD garrison facilities and will next deploy to Far East locations in October 2023.
- MHS GENESIS is being deployed across the continental United States and overseas through a total of 23 waves, with each wave targeting a specific region.